Trademarkia Logo

Canada

C$
Trademark Search in Canada
NORDICCAN

View On IC.GC.CA

NORDICCAN
REGISTERED

on 18 Oct 2023

Last Applicant/ Owned by

MEDCAN PHARMA A/S

Dandyvej 19DK-7100 Vejle

DK

Serial Number

2071516 filed on 19th Aug 2020

Registration Number

TMA1203825 registered on 18th Oct 2023

Registration expiry Date

19th Aug 2030

Correspondent Address

PERLEY-ROBERTSON, HILL & MCDOUGALL LLP

1400 - 340 ALBERT STREETOTTAWA

ONTARIO

CA

K1R0A5

NORDICCAN

Trademark usage description

pharmaceuticals for the treatment pain, neuropathic pain, fibromyalgia, multiple sclerosis (ms), carpal tunnel syndrome, sleep disorders, bacterial, f Read More

Classification Information

Class [005]
Pharmaceuticals for the treatment pain, neuropathic pain, fibromyalgia, multiple sclerosis (MS), carpal tunnel syndrome, sleep disorders, bacterial, fungal and viral skin infections, psoriasis, respiratory infections, eye infections, anxiety disorders, depression, bipolar depression, bipolar disorder, schizophrenia, diabetes, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, neurological diseases, neurodegenerative diseases, anorexia, arthritis, migraines, immune system modulation, obesity, gastrointestinal diseases, appetite loss, nausea, cancer, drug or substance addiction, benzodiazepines, gabapentinoids, non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitor (SNRIs), nicotine addiction; natural remedy preparations, namely, homeopathic remedies and natural supplements for the treatment pain, neuropathic pain, fibromyalgia, multiple sclerosis (MS), carpal tunnel syndrome, sleep disorders, bacterial, fungal and viral skin infections, psoriasis, respiratory infections, eye infections, anxiety disorders, depression, bipolar depression, bipolar disorder, schizophrenia, diabetes, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, neurological diseases, neurodegenerative diseases, anorexia, arthritis, migraines, immune system modulation, obesity, gastrointestinal diseases, appetite loss, nausea, cancer, drug or substance addiction, nicotine addiction; medicines, namely, pharmaceuticals for the treatment pain, neuropathic pain, fibromyalgia, multiple sclerosis (MS), carpal tunnel syndrome, sleep disorders, bacterial, fungal and viral skin infections, psoriasis, respiratory infections, eye infections, anxiety disorders, depression, bipolar depression, bipolar disorder, schizophrenia, diabetes, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, neurological diseases, neurodegenerative diseases, anorexia, arthritis, migraines, immune system modulation, obesity, gastrointestinal diseases, appetite loss, nausea, cancer, drug or substance addiction, benzodiazepines, gabapentinoids, non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitor (SNRIs), nicotine addiction; cannabis preparations with medical effect; dietetic preparations for medical use, namely, dietetic preparations consisting of vitamins, minerals and trace elements, dietetic food and substances adapted for medical use containing cannabis, dietetic food and substances adapted for the prevention and treatment of iron deficiency; medical confectionery, namely, gummy vitamins containing cannabis for recreational purposes; cannabis preparations for recreational consumption; nutritional preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment pain, neuropathic pain, fibromyalgia, multiple sclerosis (MS), carpal tunnel syndrome, sleep disorders, bacterial, fungal and viral skin infections, psoriasis, respiratory infections, eye infections, anxiety disorders, depression, bipolar depression, bipolar disorder, schizophrenia, diabetes, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, neurological diseases, neurodegenerative diseases, anorexia, arthritis, migraines, immune system modulation, obesity, gastrointestinal diseases, appetite loss, nausea, cancer, drug or substance addiction, nicotine addiction; nutritional preparations containing cannabis for therapeutic or medical purposes, namely, nutraceuticals for the treatment pain, neuropathic pain, fibromyalgia, multiple sclerosis (MS), carpal tunnel syndrome, sleep disorders, bacterial, fungal and viral skin infections, psoriasis, respiratory infections, eye infections, anxiety disorders, depression, bipolar depression, bipolar disorder, schizophrenia, diabetes, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, neurological diseases, neurodegenerative diseases, anorexia, arthritis, migraines, immune system modulation, obesity, gastrointestinal diseases, appetite loss, nausea, cancer, drug or substance addiction; food supplements, namely, herbal food supplements for general health and well-being, food supplements consisting of amino acids, food supplements consisting of trace elements; food supplements containing cannabis, namely herbal food supplements containing cannabis derivatives for general health and well-being, health food supplements containing cannabis derivatives for maintaining general health and wellbeing

Classification kind code

11

Class [040]
Customized manufacture of medical preparations, nutritional preparations, dietary supplements and confectionery (wage production).

Classification kind code

11

Class [042]
Development of medical products, namely, pharmaceutical preparations and medicines, and product development services in the field of nutritional preparations, namely, nutritional supplements and dietary supplements; medical research; design and development of medical technology, namely, product design and development services in the field of medical apparatus and instruments; medical and pharmacological research services

Classification kind code

11

Mark Details

Serial Number

2071516

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 5th May 2022		Agent Changed
Submitted for opposition 22
on 5th Apr 2022		Search Recorded
Submitted for opposition 20
on 5th Apr 2022		Examiner's First Report
Submitted for opposition 223
on 5th Apr 2022		Total Provisional Refusal
Submitted for opposition 256
on 18th Oct 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 17th Dec 2020		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 16th Dec 2020		Formalized
Submitted for opposition 1
on 16th Dec 2020		Created
Submitted for opposition 228
on 19th Aug 2020		International Registration
Submitted for opposition 30
on 19th Aug 2020		Filed